Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Víctor Alia-Navarro"'
Autor:
María San-Román-Gil, Iñigo Martínez-Delfrade, Víctor Albarrán-Fernández, Patricia Guerrero-Serrano, Javier Pozas-Pérez, Jesús Chamorro-Pérez, Diana Rosero-Rodríguez, Pilar Sotoca-Rubio, Ana Maria Barrill-Corpa, Víctor Alia-Navarro, Carlos González-Merino, Coral García-de-Quevedo-Suero, Victoria López, Ignacio Ruz-Caracuel, Cristian Perna-Monroy, Reyes Ferreiro-Monteagudo
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Immunotherapy has demonstrated a role in the therapeutic landscape of a small subset of patients with colorectal carcinoma (CRC) that harbor a microsatellite instability (MSI-H) status due to a deficient DNA mismatch repair (dMMR) system. The remarka
Externí odkaz:
https://doaj.org/article/764e50597193429a803f3c4afe79992e
Autor:
Pilar Sotoca Rubio, Ana María Barrill Corpa, Víctor Alia Navarro, Patricia Pérez de Aguado Rodríguez, Jaime Moreno Doval, Juan Carlos Calvo Pérez, Patricia Guerrero Serrano, Carlos García Merino, Coral García de Quevedo Suero, Jorge Fernández-Fradejas, Juan José Serrano Domingo, Íñigo Martínez Delfrade, Blanca Isabel Morón García, María Reyes Ferreiro Monteagudo, Belén de Frutos González
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionRegorafenib is indicated as treatment in third-line and beyond in patients with metastatic colorectal cancer.Methods This is a retrospective study of a cohort of patients with mCRC treated with regorafenib in Hospital Universitario Ramón
Externí odkaz:
https://doaj.org/article/c7f2e404014b4c869d247428e5915dce